Table 1.
Baseline Demographic and Clinical Characteristics of Patients Enrolled in This Study.
| Characteristic | Total (N = 63) | NLR low (N = 30) | NLR high (N = 33) | P value* |
|---|---|---|---|---|
| Age, median (Q1, Q3), years | 51（44-60） | 51（44-57） | 51（43-61） | 0.940 |
| Sex, male/female | 57/6 | 25/5 | 32/1 | 0.158 |
| ECOG PS, 0/1 | 53/10 | 26/4 | 27/6 | 0.857 |
| BMI, median (Q1, Q3), kg/m2 | 23.1（20.8-25.1） | 22.3（20.1-25.0） | 23.4（20.8-25.1） | 0.477 |
| Etiology, HBV/Nonviral | 48/15 | 22/8 | 26/7 | 0.612 |
| PLT, median (Q1, Q3), 10^9/L | 187（141-221） | 180（140-221） | 187（136-222） | 0.834 |
| Cr, median (Q1, Q3), μmol/L | 74（66-85） | 73（66-83） | 76（65-86） | 0.735 |
| Child–Pugh score, 5/6/7 | 51/9/3 | 24/4/2 | 27/5/1 | 0.785 |
| ALBI, Grade 1/2 | 38/25 | 16/14 | 22/11 | 0.280 |
| AFP, ≥/<400, ng/ml | 22/41 | 10/20 | 12/21 | 0.801 |
| Target tumor size, ≥/<7.4, cm | 33/30 | 17/13 | 16/17 | 0.516 |
| Target tumor numbers, 1/2/≥3 | 15/42/6 | 8/18/4 | 7/24/2 | 0.481 |
| MVI, +/- | 21/42 | 8/22 | 13/20 | 0.285 |
| EHS, +/- | 33/30 | 19/11 | 14/19 | 0.097 |
| BCLC, B/C | 19/44 | 7/23 | 12/21 | 0.260 |
Note: Values are expressed as numbers or medians (Q1, Q3), Q1, and Q3 are 25th percent and 75th percent of interquartile range.
*P values showed the comparison results of baseline characteristics between NLR low group and NLR high group.
Abbreviations: NLR, neutrophil-to-lymphocyte ratio; ECOG, Eastern Cooperative Oncology Group; BMI, body mass index; PLT, platelet; Cr, creatinine; AFP, α-fetoprotein; MVI, macroscopic vascular invasion; EHS, extrahepatic spread; BCLC, Barcelona Clinical Liver Cancer system.